Rational design of tumor-microenvironment (TME)-activated nanoformulation for precisely
targeted cancer treatment has recently attracted an enormous attention. However, the all-in …

The combination of phototherapy and chemotherapy holds great potential for cancer
treatment, while hypoxia in tumor as well as unexpected drug release largely restricts …

The uncontrolled treatment process and high concentration of intracellular glutathione
compromise the therapeutic efficacies of chemodynamic therapy (CDT). Here, iron oxide …

Activatable theranostic agents that can be activated by tumor microenvironment possess
higher specificity and sensitivity. Here, activatable nanozyme‐mediated 2, 2′‐azino‐bis (3 …

Activatable nanosystem for cancer therapy are of considerable attention in the field of
theranostics. Nevertheless, constructing activatable nanosystem with specific response …

Intrinsic tumor microenvironment (TME)-related therapeutic resistance and nontumor-
specific imaging have limited the application of imaging-guided cancer therapy. Herein, a …

Synergistic therapy is expected to be a promising strategy for highly effective cancer
treatment. However, the rational design of a simple and multifunctional nanoplatform still …

The specific in situ generation and activation of therapeutic agents with high spatiotemporal
precision is expected to revolutionize cancer treatment. Here, we develop an intelligent …

Adenosine triphosphate (ATP), as a key substance for regulating tumor progression in the
tumor microenvironemnt (TME), is an emerging target for tumor theranostics. Herein, we …

Developing highly efficient chemodynamic therapy (CDT)-based theranostic technology for
cancer treatment is highly desired but still challenging. A novel nanotheranostic platform is …